Workshops at Advanced Therapies Week 2026
Our workshops are designed for teams who want to go deeper. These are small-format, expert-led sessions that move beyond theory into real-world application. Expect candid discussion, practical frameworks, and direct access to the people shaping how cell and gene therapies are developed, manufactured, and scaled.
Tuesday, February 10 2026 | 08:00 – 09:00 | Theatre 2
This workshop examines Quality Control as a full end-to-end continuum, not just a final release checkpoint. The discussion focuses on where real QC bottlenecks form, how automation is already improving throughput and consistency, and where AI-driven analytics can add value without introducing unnecessary complexity, giving teams practical guidance for building QC workflows that can support higher volumes and faster decision-making.
Register your interest
Tuesday, February 10 2026 | 08:00 – 09:00 | Theatre 1
Industry leaders come together to explore how automation, modular platforms, and flexible workflows are shaping end-to-end cell therapy manufacturing across both autologous and allogeneic modalities. This session focuses on real-world challenges from early process development through to clinical and commercial scale, offering practical insights into how integrated, scalable approaches can reduce complexity, improve consistency, and support long-term manufacturing success.
Register your interest
Tuesday, February 10 2026 | 12:30 – 01:00 | Theatre 2
A panel of cross-functional subject matter experts share practical lessons learned from real commercial launches, covering regulatory readiness, process characterization, PPQ, PLI readiness, clinical operations, and supply chain planning. Attendees will also complete a high-level commercial readiness checklist and have the opportunity to submit it for post-conference feedback from the panel.
Register your interest
Tuesday, February 10 2026 | 12:30 – 01:30 | Theatre 1
This workshop examines how automated flow cytometry can be rapidly implemented in GMP cell therapy manufacturing to improve in-process testing efficiency and maximize cell availability. The session focuses on practical applications, regulatory and validation considerations, and emerging use cases for automated phenotyping within compliant manufacturing environments.
Tuesday, February 10 2026 | 01:15 – 01:45 | Theatre 2
This workshop explores how automated flow cytometry can support efficient, compliant in-process testing within cell and gene therapy manufacturing. Focusing on applications that improve manufacturing efficiency and maximize cell availability for dose preparation, the session examines the role of automation in meeting ICH and pharmacopeial requirements, alongside practical approaches to building robust analytical platforms and validating flow cytometry methods in GMP environments.
Register your interest
Tuesday, February 10 2026 | 03:45 – 04:45 | Theatre 2
This workshop brings together independent evaluation and peer experience to examine how closed and automated manufacturing approaches can reduce contamination risk, manual interventions, and scalability challenges. Through expert presentations and panel discussion, attendees will gain evidence-based insights into solution evaluation, validation expectations, and when to introduce automation across clinical development stages.
Wednesday, February 11 2026 | 08:00 – 09:00 | Theatre 1
This workshop focuses on how early decisions around media formulation, raw material strategy, and process design directly impact tech transfer success, cost of goods, and regulatory readiness, particularly for MSC therapies. The session explores how integrating development services and automation early can de-risk scale-up and accelerate time-to-patient.
Wednesday, February 11 2026 | 08:00 – 08:30 | Theatre 2
This workshop explores how digital integration and scalable MES solutions can enable more efficient, connected cell therapy manufacturing operations, helping teams accelerate timelines, improve data visibility, and support future scale. Further details will be announced shortly.
Wednesday, February 11 2026 | 12:30 – 01:30 | Theatre 1
This interactive roundtable brings together experts to explore the technical, clinical, and regulatory considerations shaping the future of in vivo CAR-T. Through facilitated breakout discussions, participants will examine development strategy, patient safety and experience, and what long-term success looks like for this emerging therapeutic approach.
Register your interest
